Dong-E-E-Jiao Co.,Ltd. (SHE: 000423)

Market Cap	32.75B
Revenue (ttm)	5.30B
Net Income (ttm)	1.36B
Shares Out	642.46M
EPS (ttm)	2.11
PE Ratio	24.11
Forward PE	20.32
Dividend	1.78 (3.50%)
Ex-Dividend Date	Sep 10, 2024

Volume	4,520,501
Open	51.30
Previous Close	50.98
Day's Range	50.56 - 51.47
52-Week Range	44.52 - 72.91
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About Dong-E-E-Jiao Co.,Ltd.

Dong-E-E-Jiao Co.,Ltd. research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods. The company was founded in 1952 and is based in Liaocheng, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 3,678
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000423

Financial Performance

In 2023, Dong-E-E-Jiao Co.,Ltd.'s revenue was 4.72 billion, an increase of 16.66% compared to the previous year's 4.04 billion. Earnings were 1.15 billion, an increase of 47.55%.